hotspot -WSS

hotspot

author：hotspot 2025-10-01 00:48:17 - browse：32452

WICHITA, Kan. -- A second suspect is now in custody in connection with a mass shooting that injured nearly a dozen people earlier this month in Kansas, Wichita police announced Monday.

A 27-year-old man was arrested on suspicion of aggravated battery and possession of a firearm by a felon. On Friday, a 19-year-old man was arrested. It wasn't immediately clear if either man has been charged. Their names have not been released. A message left with Sedgwick County District Attorney Marc Bennett wasn't immediately returned.

The shooting happened in the early hours of July 2 at City Nightz in downtown Wichita. Nine people were shot and two others were trampled in the chaos that followed. No one died.

In addition to the arrests, police are searching for a 23-year-old man believed to have been involved in the shooting. A St. Louis-area man was arrested July 3, but prosecutors later determined he fired his gun to defend himself after shots were fired by two other men at the club.

The gunshot victims — seven men and two women — ranged in age from 22 to 34, police said. The two people trampled were a 30-year-old woman and a 31-year-old male.

Wichita is a city of nearly 400,000 people, located about 200 miles (320 kilometers) southwest of Kansas City, Missouri.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Organ transplantation is at a crossroads. Major reform is needed

WSS

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Elizabeth Warren probes abortion access

How artificial intelligence is being used to detect, treat cancer

Food makers to regulators: Ultra

What to make of Biden’s latest efforts on cancer research

PEPFAR is under serious threat — and so is global health

hotspot

hotspot

Wikipedia

Medical records are filled with copy

New Covid vaccine is recommended for everyone 6 months or older

Medical records are filled with copy

New Covid vaccine is recommended for everyone 6 months or older

Affirmative action in medical school literally saved lives

How to make the FDA’s new prescription one

New air purifier tech could be key to improving indoor air quality

IRA could hurt research into orphan drugs for rare diseases

Novavax promises a turnaround & Lilly roils the obesity market

Diverse clinical trials: Why aren’t we there yet?

knowledge

Caitlin Bernard's story shows physicians can't shy from advocacy

Diverse clinical trials: Why aren’t we there yet?

Long Covid needs a new name — and a new frame

AbbVie dramatically boosts its spending on lobbying

PEPFAR is under serious threat — and so is global health

FDA official pushes for dedicated emerging pathogens team

focus

hotspot

focus

knowledge